Fig. 1From: Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphismsStepwise exclusions of population subsets ineligible for Plasmodium vivax radical cure by primaquine. Red boxes indicate excluded subsets, while green are eligible. AS activity score, G6PDd G6PD deficient, hemi hemizygote, hetero heterozygote, homo homozygote, PQ primaquineBack to article page